Phage Against the Routine: Resistant Acinetobacter

<p>Defined as ​an “urgent” AMR threat by the US CDC, resistant <em>Acinetobacter baumanii </em>cause deadly infections and are difficult to remove from the environment. <em>Acinetobacter </em>is resistant to many antibiotics and is a frequent cause of hospital acquired infections. In the 2022 Lancet publication on drug-resistant infections (GRAM report), it was identified as the leading pathogen causing mortality in Southeast Asia. This episode will cover how infections caused by resistant <em>Acinetobacter</em> impact patients and on how new treatments are making an impact.</p> <h4><strong>Guests:</strong></h4> <p><strong>Steffanie Strathdee</strong> - Associate Dean of Global Health Sciences, University of California San Diego School of Medicine; Author, <a href="https://theperfectpredator.com/"><em>The Perfect Predator</em></a></p> <p><strong>Greg Merril</strong> - CEO, Adaptive Phage Therapeutics</p> <p><strong>Patrick McGann</strong> - Deputy Director, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN)</p> <p><strong>Jason Bennett&nbsp;</strong>- Director, MRSN; Associate Professor of Medicine, Walter Reed Army Institute of Research</p>